Illumina Inc. (NASDAQ: ILMN) is a large market cap stock with a market cap of 27325.66. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 64, a forward P/E of 45.57 and EPS of 2.91. At a stock price of 186.17 (2.73%) it has a dividend yield of *TBA.
EPS growth for the last five years have been 28.90%, more recently this last year it has grown by 30.50%. The next year growth is going to be about 15.72% and more long-term 15.97% after five years. EPS growth quarter over quarter is 18.60%. Sales growth for the past five years have been 19.70% and sales growth quarter over quarter is 11.30%.
For performance, Illumina Inc. the past week has seen a gain of 2.87%. For the last month performance for Illumina Inc. is 9.40%. While the last quarter is 32.92% and half year, 10.68%. Finally for the year, performance is 27.68%.
The 52-week high for Illumina Inc., is at -5.24%, and for the 52-week low it comes to a value of 46.48%. The 20-day simple moving average is 8.82% and 18.14% for the 200-day simple moving average.
Volatility for the week is at 3.10%, and for the month it is 2.40%. Illumina Inc., has a target price of 155.67.
In terms of debt, long term debt/equity is 0.5, and for total debt/equity Illumina Inc. has 0.5. The gross margin is 70.00%, while operating margin is 24.60%, the profit margin is 18.70%. The current ratio is 3.7 and the quick ratio is 3.1.
Insider ownership is at 1.00%, with instituitional ownership at 97.70%. Illumina Inc. has a payout ratio of 0.00%. With the total shares outstanding coming to 146.78. The shares float is 145.1, with the float short at 3.47%, with short ratio coming to 4.86.
In terms of returns, the return on assets see Illumina Inc., get 11.40%, with its returns on investment at 16.60%. Return on equity is 22.10%. So will the investors see the target price of 155.67, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.